Moderna Inc (NASDAQ: MRNA) on Friday, soared 6.08% from the previous trading day, before settling in for the closing price of $22.36. Within the past 52 weeks, MRNA’s price has moved between $22.32 and $48.92.
During the last 5-year period, the sales drop of Healthcare Sector giant was -42.94%. The company achieved an average annual earnings per share of 12.81%. With a float of $346.52 million, this company’s outstanding shares have now reached $391.00 million.
Moderna Inc (MRNA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Moderna Inc is 11.30%, while institutional ownership is 70.24%. The most recent insider transaction that took place on Jun 11 ’25, was worth 8,736. In this transaction Director of this company sold 312 shares at a rate of $28.00, taking the stock ownership to the 580 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 312 for $28.00, making the entire transaction worth $8,736.
Moderna Inc (MRNA) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -2.91 earnings per share (EPS) for the period falling under the consensus outlook (set at -2.76) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.93% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Moderna Inc (MRNA) is currently performing well based on its current performance indicators. A quick ratio of 3.73 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.06, a number that is poised to hit -2.64 in the next quarter and is forecasted to reach -6.81 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Looking closely at Moderna Inc (NASDAQ: MRNA), its last 5-days average volume was 11.71 million, which is a jump from its year-to-date volume of 10.97 million. As of the previous 9 days, the stock’s Stochastic %D was 19.60%.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 10.82%, which indicates a significant decrease from 29.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.41 in the past 14 days, which was higher than the 1.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.87, while its 200-day Moving Average is $28.00. However, in the short run, Moderna Inc’s stock first resistance to watch stands at $24.35. Second resistance stands at $24.97. The third major resistance level sits at $26.01. If the price goes on to break the first support level at $22.69, it is likely to go to the next support level at $21.65. Now, if the price goes above the second support level, the third support stands at $21.03.
Moderna Inc (NASDAQ: MRNA) Key Stats
Market capitalization of the company is 9.27 billion based on 390,734K outstanding shares. Right now, sales total 3,236 M and income totals -3,561 M. The company made 1,016 M in profit during its latest quarter, and -200,000 K in sales during its previous quarter.
